← Back to Search

Behavioural Intervention

Training program for Spastic Ataxia

N/A
Waitlist Available
Led By Cynthia Gagnon, PhD
Research Sponsored by Élise Duchesne
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Genetically confirmed ARSACS diagnosis; walker (indoor walking abilities with or without walking aids); ability to walk 10 meters; ability to provide informed consent
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, week 4, week 8
Awards & highlights
No Placebo-Only Group

Summary

This exploratory study used a pre-post test design. The supervised rehabilitation program was performed three times a week for 8 weeks (two sessions at a rehabilitation gym and one pool session). Outcome measures included Ottawa sitting scale, 30-Second Chair Stand test, Berg Balance Scale, 10-Meter Walk Test, 6-minute Walk Test, modified Activities-specific Balance Confidence Scale and SARA scale. 10 participants will complete the training program. They will be evaluated at baseline, at week 4 (miway) and after the program.

Eligible Conditions
  • Spastic Ataxia

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, week 4, week 8
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, week 4, week 8 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Ataxia
Secondary study objectives
Change in balance
Change in sitting balance
Change in the balance confidence
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Training programExperimental Treatment1 Intervention
8-week rehabilitation program aimed at increasing trunk and lower limb motor control on balance and walking abilities, and accomplishment of activities of daily living.

Find a Location

Who is running the clinical trial?

Élise DuchesneLead Sponsor
2 Previous Clinical Trials
23 Total Patients Enrolled
Muscular Dystrophy CanadaOTHER
3 Previous Clinical Trials
157 Total Patients Enrolled
Cynthia Gagnon, PhDPrincipal InvestigatorSherbrooke University
~2 spots leftby Dec 2025